2016
Artesunate-Amodiaquine and Artemether-Lumefantrine Therapies and Selection of Pfcrt and Pfmdr1 Alleles in Nanoro, Burkina Faso
Sondo P, Derra K, Nakanabo S, Tarnagda Z, Kazienga A, Zampa O, Valéa I, Sorgho H, Owusu-Dabo E, Ouédraogo J, Guiguemdé T, Tinto H. Artesunate-Amodiaquine and Artemether-Lumefantrine Therapies and Selection of Pfcrt and Pfmdr1 Alleles in Nanoro, Burkina Faso. PLOS ONE 2016, 11: e0151565. PMID: 27031231, PMCID: PMC4816516, DOI: 10.1371/journal.pone.0151565.Peer-Reviewed Original ResearchMeSH KeywordsAdultAgedAllelesAmodiaquineAntimalarialsArtemether, Lumefantrine Drug CombinationArtemisininsBurkina FasoChildDrug CombinationsEthanolaminesFemaleFluorenesGene FrequencyGenotypeHost-Parasite InteractionsHumansMalaria, FalciparumMaleMembrane Transport ProteinsMiddle AgedMultidrug Resistance-Associated ProteinsMultivariate AnalysisParasitemiaPlasmodium falciparumPolymorphism, Single NucleotideProtozoan ProteinsTreatment OutcomeConceptsPfmdr1 allelesTreatment failureArtemether-lumefantrine therapyPfcrt K76TSingle nucleotide polymorphismsRestriction fragment length polymorphism methodFragment length polymorphism methodPotential beneficial effectsLength polymorphism methodArtesunate-AmodiaquineRecurrent parasitaemiaTreatment regimenACT resistanceCombination therapyK76TPfmdr1 geneClinical trialsTreatment outcomesMultivariate analysisDay 0PfcrtMalaria controlBlood spotsBeneficial effectsPolymorphism method
2015
Safety and efficacy of re-treatments with pyronaridine-artesunate in African patients with malaria: a substudy of the WANECAM randomised trial
Sagara I, Beavogui A, Zongo I, Soulama I, Borghini-Fuhrer I, Fofana B, Camara D, Somé A, Coulibaly A, Traore O, Dara N, Kabore M, Thera I, Compaore Y, Sylla M, Nikiema F, Diallo M, Dicko A, Gil J, Borrmann S, Duparc S, Miller R, Doumbo O, Shin J, Bjorkman A, Ouedraogo J, Sirima S, Djimdé A. Safety and efficacy of re-treatments with pyronaridine-artesunate in African patients with malaria: a substudy of the WANECAM randomised trial. The Lancet Infectious Diseases 2015, 16: 189-198. PMID: 26601738, PMCID: PMC4726763, DOI: 10.1016/s1473-3099(15)00318-7.Peer-Reviewed Original ResearchConceptsSubstudy analysisFirst episodeFirst treatmentArtemisinin-based combination treatmentDeveloping Countries Clinical Trials PartnershipPrimary safety endpointPyronaridine-artesunate efficacyHistory of feverIncidence of hepatotoxicityAdverse event frequencyExclusion of patientsUK Medical Research CouncilMedical Research CouncilParasitological responseSafety endpointArtemether-lumefantrineMalaria episodesTreat analysisAfrican patientsMalaria treatmentClinical trialsMalaria VentureLaboratory valuesAlanine aminotransferaseHealth facilities
2009
Phylogenetic Analysis of Human Parvovirus B19 Sequences from Eleven Different Countries Confirms the Predominance of Genotype 1 and Suggests the Spread of Genotype 3b
Hübschen J, Mihneva Z, Mentis A, Schneider F, Aboudy Y, Grossman Z, Rudich H, Kasymbekova K, Sarv I, Nedeljkovic J, Tahita M, Tarnagda Z, Ouedraogo J, Gerasimova A, Moskaleva T, Tikhonova N, Chitadze N, Forbi J, Faneye A, Otegbayo J, Charpentier E, Muller C. Phylogenetic Analysis of Human Parvovirus B19 Sequences from Eleven Different Countries Confirms the Predominance of Genotype 1 and Suggests the Spread of Genotype 3b. Journal Of Clinical Microbiology 2009, 47: 3735-3738. PMID: 19741071, PMCID: PMC2772644, DOI: 10.1128/jcm.01201-09.Peer-Reviewed Original Research
2001
Preliminary study of cutaneous leishmaniasis in the town of Ouagadougou from 1996 to 1998.
Traoré K, Sawadogo N, Traoré A, Ouedraogo J, Traoré K, Guiguemdé T. Preliminary study of cutaneous leishmaniasis in the town of Ouagadougou from 1996 to 1998. Bulletin De La Société De Pathologie Exotique 2001, 94: 52-5. PMID: 11346985.Peer-Reviewed Original ResearchConceptsCutaneous leishmaniasisClinical formsHealth centersMonths of progressionAge of patientsFrequent clinical formPublic Health CenterDifferent clinical formsSite of infectionHealth care staffReports of casesProtocol therapyProspective studyRetrospective studyMean ageLocal etiologyInferior limbHigh incidenceCommon locationPatientsCare staffClinical casesCase managementDecisional algorithmLeishmaniasis
1997
Malaria morbidity in adults living in urban Burkina Faso.
Guiguemde T, Ouedraogo I, Ouedraogo J, Coulibaly S, Gbary A. Malaria morbidity in adults living in urban Burkina Faso. Medecine Tropicale 1997, 57: 165-8. PMID: 9304011.Peer-Reviewed Original ResearchConceptsLevel of immunizationPoor positive predictive valueSerious public health problemMain clinical featuresPublic health problemDiagnosis of malariaBobo-DioulassoPositive predictive valueParasitic indexMedian parasitemiaClinical featuresClinical symptomsMalaria morbidityProspective studyParasitological featuresParasite densityHigh incidencePlace of residencePredictive valueHealth problemsEndemic malariaMalariaUrban Burkina FasoAdultsMicroscopic examination